中文产业新闻评分64Chinese source
礼来替尔泊肽获 FDA 批准用于降低 2 型糖尿病患者心血管不良事件风险
礼来替尔泊肽获批新适应症！
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
礼来替尔泊肽获批新适应症！
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.